Intel's Bipolar Market: Record Sales, an $11 Billion Accounting Hit, and a Rival's Unlikely Compliment

Intel posts fastest revenue growth in 15 years but stock drops 30% in a month; a competitor's pivot sparks 13% surge, highlighting market perception swings.

There are two ways to read Intel's recent stretch on Wall Street, and both are technically true. The company just posted its fastest quarterly revenue growth in over 15 years, and its stock has been punished as if the opposite had happened. Then, in a single Thursday session, a report about a competitor's strategic pivot sent the shares soaring roughly 13% — a reminder that in the semiconductor trade, perception can shift faster than a wafer can be processed.

The whiplash is the story.

The Quarter That Confused Everyone

When Intel reported on July 23, the headline numbers looked like a clean victory lap. Revenue hit $16.1 billion against forecasts of $14.42 billion, with adjusted earnings per share of 42 cents crushing the 21-cent consensus. The data center and AI segment led the charge, surging 59% year over year to $6.3 billion.

But the accounting optics told a different story. Under US GAAP, Intel posted a staggering $11 billion loss — $2.16 per share — driven by a $12.5 billion valuation writedown on trust shares tied to its CHIPS Act agreement with the US government. The stock dropped nearly 8% the following day, even though virtually every operational metric beat expectations.

That disconnect between the operating reality and the reported bottom line has become the central tension for investors. The operating margin tells the more flattering version: it expanded from 16.1% to 39.5%, while the client computing and physical AI segment accelerated from 1% growth in Q1 to 13% in Q2. Over the trailing twelve months, the company's operating margin climbed to roughly 7.6%, a dramatic swing from the negative 8.3% posted in the prior-year period.

The Market's Mood Swing

Despite the strong fundamentals, the equity has been anything but stable. Over the past month, Intel shares have shed nearly 30% of their value, landing at EUR 78.42 by Friday's close. That's 37% below the year's high of EUR 124.58 — yet still about 34% above the 200-day moving average. The RSI sits at 39.2, a neutral-to-slightly-oversold reading that suggests the selling pressure may be more about position unwinding than structural deterioration.

The stock also trades roughly 20.5% below its 50-day average, a sign that short-term momentum has cooled considerably. On Friday alone, the shares slipped 0.78%, contributing to a 3.45% weekly decline.

The sell-off followed a parabolic run that saw the stock gain around 150% since the start of the year. For many observers, the correction looks less like a verdict on the turnaround and more like a market that simply got ahead of itself in June and is now paying the price.

Wall Street Isn't Backing Away

What makes the recent pullback notable is who isn't joining the pessimism. Bernstein's Stacy Rasgon has expressed as much confidence in Intel as he has in some time. HSBC's Frank Lee pointed out that the market is reading this quarter entirely differently than it did the previous one — a nod to the gap between the GAAP loss and the operational improvement. Bank of America went a step further, upgrading the stock in a rare double-step move, citing the AI-driven revaluation of the business model.

That's not the tone of analysts losing faith in the turnaround. It reads more like market participants trying to contextualize a violent correction following an unsustainable spike.

The Foundry Puzzle

The foundry business remains the linchpin of the entire thesis. Revenue in the segment grew 31% year over year to roughly $5.8 billion, and the 18A production process is reportedly ahead of the schedule of previous chip generations, according to the CFO. Investment in the foundry operation is expected to increase again next year.

But the external customer story is still thin. Outside revenue amounts to just $293 million — approximately 5% of total foundry sales — while the segment posted an operating loss of around $2.1 billion. The execution risks that have dogged Intel for years haven't disappeared; they've just been temporarily overshadowed by the packaging news.

TSMC's Accidental Endorsement

That news arrived Thursday when The Information reported that TSMC — Intel's fiercest rival — is developing its own version of Intel's EMIB packaging technology with partner Kinsus Interconnect Technology. EMIB uses silicon bridges to connect multiple chip components, enabling larger, more complex processors with greater efficiency and lower manufacturing costs.

The technology has already attracted marquee customers: Nvidia, Google, and OpenAI are all using EMIB, and Nvidia is reportedly evaluating it for a future processor. TSMC's interest is hardly surprising given its own capacity crunch — its competing CoWoS packaging is fully booked through 2026, with lead times stretching to 78 weeks.

The market read TSMC's move as validation. If the strongest competitor is copying Intel's approach, the logic goes, then Intel Foundry's progress under CEO Lip-Bu Tan must be real. TSMC shares rose 7.6% on the day; Intel jumped about 13%.

What Comes Next

For the third quarter, management guides for revenue between $15.8 billion and $16.8 billion, with GAAP earnings per share of $0.31 and adjusted EPS of $0.38. The real test, however, isn't the guidance — it's whether the hyperscalers' interest in EMIB translates into actual foundry orders.

The stock's extreme volatility cuts both ways, and further sharp swings are likely in either direction. But a company with its fastest growth in 15 years, expanding foundry revenue, and newly restored analyst support doesn't typically justify a nearly 30% drawdown in four weeks. The current picture looks less like a failed transformation and more like a market that overextended itself and is now working off the excess. When the selling pressure abates, the setup for stabilization is arguably in place.